| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
616 |
| Employees |
3 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Regen BioPharma Inc is a publicly traded biotechnology company that specializes in developing innovative cellular therapies and immune system modulation for the treatment of various cancers and autoimmune diseases. The company has its headquarters in La Mesa, California, USA.
Regen BioPharma was founded in 2012 and has since then built a reputable name for itself in the biotechnology industry. The company's scientific team comprises of renowned experts in the field of cancer immunotherapy and life sciences research, which have earned several awards and recognition for their outstanding research work.
The company's product pipeline consists of several novel technologies that aim to target specific cellular pathways responsible for the development and progression of cancer and autoimmune diseases. These include therapies that target the body's immune system to attack cancer cells or autoimmune cells, as well as small molecule inhibitors that target enzymatic activity in tumors.
Regen BioPharma has also made significant strides in the field of gene therapy, with several patents already issued for technology to target cancer cells with gene therapy vectors. The company's products are in various stages of development and clinical testing, with some already in clinical trials.
In addition to its drug development activities, Regen BioPharma has also acquired other companies to expand its portfolio of technologies and products. Acquisitions include Killesk Pharma, which specializes in developing novel small molecule inhibitors for cancer treatment, and HLS Therapeutics, which focuses on gene therapy technologies for the treatment of genetic disorders.
Regen BioPharma is dedicated to making innovative therapies available to patients in dire need of better treatment options for cancer and autoimmune diseases. The company's ultimate goal is to bring groundbreaking therapies to the market that can improve patients' lives and potentially cure debilitating diseases.
Company Address: 8697 La Mesa Blvd La Mesa 91942 CA
Company Phone Number: 722-5505 Stock Exchange / Ticker: RGBP
|
0.000%
7.33%